About Gamida Cell
Gamida Cell is a company based in Jerusalem (Israel) founded in 1998.. Gamida Cell has raised $139.12 million across 12 funding rounds from investors including Amgen, Novartis and Teva Pharmaceuticals. Gamida Cell offers products and services including NAM-based Cell Therapies. Gamida Cell operates in a competitive market with competitors including Jazz Pharmaceuticals, Moderna, BridgeBio, C4 Therapeutics and Erasca, among others.
- Headquarter Jerusalem, Israel
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Gamida Cell Ltd.
-
Annual Revenue
$1.78 M0as on Dec 31, 2023
-
Net Profit
$63 M-21as on Dec 31, 2023
-
EBITDA
$73.04 M-3as on Dec 31, 2023
-
Total Equity Funding
$139.12 M (USD)
in 12 rounds
-
Latest Funding Round
$3.5 M (USD), Grant
Jul 20, 2017
-
Investors
Amgen
& 13 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Gamida Cell
Gamida Cell offers a comprehensive portfolio of products and services, including NAM-based Cell Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enhances cells for potentially curative treatments of hematologic malignancies
Unlock access to complete
Unlock access to complete
Funding Insights of Gamida Cell
Gamida Cell has successfully raised a total of $139.12M across 12 strategic funding rounds. The most recent funding activity was a Grant round of $3.5 million completed in July 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Grant — $3.5M
-
First Round
First Round
(01 May 2000)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2017 | Amount | Grant - Gamida Cell | Valuation |
investors |
|
| Jun, 2017 | Amount | Series G - Gamida Cell | Valuation | Shavit Capital | |
| May, 2016 | Amount | Grant - Gamida Cell | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Gamida Cell
Gamida Cell has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include Amgen, Novartis and Teva Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments in Israel are managed by Shavit Capital.
|
Founded Year | Domain | Location | |
|
Life Sciences focused VC firm investing in Israel and the US
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Gamida Cell
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Gamida Cell
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gamida Cell Comparisons
Competitors of Gamida Cell
Gamida Cell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Moderna, BridgeBio, C4 Therapeutics and Erasca, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Gamida Cell
Frequently Asked Questions about Gamida Cell
When was Gamida Cell founded?
Gamida Cell was founded in 1998 and raised its 1st funding round 2 years after it was founded.
Where is Gamida Cell located?
Gamida Cell is headquartered in Jerusalem, Israel. It is registered at Jerusalem, Jerusalem District, Israel.
Who is the current CEO of Gamida Cell?
Joseph Wiley is the current CEO of Gamida Cell.
Is Gamida Cell a funded company?
Gamida Cell is a funded company, having raised a total of $139.12M across 12 funding rounds to date. The company's 1st funding round was a Grant of $4.4M, raised on May 01, 2000.
What is the annual revenue of Gamida Cell?
Annual revenue of Gamida Cell is $1.78M as on Dec 31, 2023.
What does Gamida Cell do?
The company was founded in 1998 in Jerusalem, Israel, and operates in the biotechnology sector. Cell therapies are developed using a proprietary NAM platform for allogeneic sources, including umbilical cord blood-derived cells and NK cells, targeted at solid tumors and hematological malignancies. The lead product, omidubicel, is focused on treating hematological malignancies, with operations centered on advancing these therapies for serious diseases.
Who are the top competitors of Gamida Cell?
Gamida Cell's top competitors include Moderna, Jazz Pharmaceuticals and Spark Therapeutics.
What products or services does Gamida Cell offer?
Gamida Cell offers NAM-based Cell Therapies.
Who are Gamida Cell's investors?
Gamida Cell has 14 investors. Key investors include Amgen, Novartis, Teva Pharmaceuticals, Israel Innovation Authority, and Clal Biotechnology Industries.